Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
GLP-1 Users for Weight Management represent a 31.8% share, driven by the widespread adoption of GLP-1 receptor agonists specifically for obesity and weight management, along with the corresponding demand for protein, hydration, and micronutrient support to mitigate side effects and maintain nutritional balance
1,951.00 Rs
Beyond orforglipron, several other non-peptide oral GLP-1 agonists are in clinical development, and oral dual agonists (targeting both GLP-1 and GIP receptors) are in preclinical stages
This approach aims to maintain more stable levels of the peptide in the system throughout a 24-hour period, which can be beneficial for ongoing repair and recovery processes
US$ 20.77
US$ 24.21
US$ 23.34
US$ 26.39
US$ 26.95
:max_bytes(150000):strip_icc()/top-causes-of-red-eye-34221111-c8c228c886874119b5ceffbceba872c4.png)
